Clinical study to evaluate the Immunomodulatory effect of swarnaprashan in children under 5 years of age
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Relief from recurrent infection
研究概览
简要总结
Children are vulnerable to infection because their immune system less developed. The urgent need for collective action to enhance children’s survival rates worldwide parallels the critical importance of childhood growth and development. Early childhood development is complex, involving various dimensions such as physical, social, emotional and mental aspects. so many vaccines are available for infectious diseases and antibiotics are successful in fighting the infections but emergence of antibiotic resistance is a great challenge in the present era. Also, frequent use of antibiotics creates lot of side-effects which also adversely affect the growth and development of the child. Childhood is a fragile age and too many vaccine shots and antibiotics may result in dangerous side effects in children. There is a strong need to develop nonspecific immunity in children which help them to fight against recurrent infections. Modern medical science lacks adequate management strategies to prevent such recurrences and enhance the immune system. However, ancient literature, particularly the Kashyap Samhita, provides us with valuable insights into immunomodulatory practices like Swarnaprashan, aimed at preventing children from infections and promoting their physical and mental growth.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- None
入排标准
- 年龄范围
- 6.00 Month(s) 至 5.00 Year(s)(—)
- 性别
- All
入选标准
- •Children aged between 06 Month to 05 years of either sex.
- •Children with recurrent respiratory infections.
- •Children with recurrence of fever and other infection.
- •Children with recurrence of gastro intestinal infection.
- •Children delay with growth and development.
排除标准
- •Children suffering from major systemic illness necessitating long term treatment.
- •Children with evidence of malignancy, genetic or congenital anomaly.
- •Co-morbidity like TB, UTI and bleeding disorders etc.
结局指标
主要结局
Relief from recurrent infection
时间窗: 28 days
and increase immunity
时间窗: 28 days
次要结局
- compare the immunomodulatory effect of both group(28 days)
研究者
Dr Saloni Ranawat
Madan Mohan Malviya Government Ayurved College
